Biologics and tuberculosis risk: the rise and fall of an old disease and its new resurgence
J Rheumatol Suppl
.
2014 May:91:1-3.
doi: 10.3899/jrheum.140095.
Authors
Fabrizio Cantini
1
,
Delia Goletti
Affiliation
1
Address correspondence to Prof. Cantini, Rheumatology Division, Hospital of Prato, Piazza Ospedale, 1 59100 Prato, Italy. E-mail: fbrzcantini@gmail.com.
PMID:
24788993
DOI:
10.3899/jrheum.140095
No abstract available
Publication types
Introductory Journal Article
MeSH terms
Biological Products / adverse effects*
Humans
Incidence
Risk
Tuberculosis / epidemiology*
Tuberculosis / etiology
Substances
Biological Products